Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 559 of 5804
-
HIV breakthrough trial seeks to rescue failing treatments in africa
Disease control Recruiting nowThe RESOLVE trial is an open, parallel arm, randomized clinical trial which aims to determine the optimal strategy for management of virologic failure on antiretroviral therapy (ART) with tenofovir, lamivudine, and dolutegravir (TLD) in sub-Saharan Africa. The primary outcome of …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New combo therapy targets tough lung cancer
Disease control OngoingThis study is for patients with advanced/metastatic non-small cells lung cancer (NSCLC) who have not received any treatment through the vein for the advanced disease.
Phase: PHASE2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New weekly shot shows promise for shedding pounds in obesity trial
Disease control CompletedThis study in China is open to adults who are at least 18 years old who are living with overweight or obesity. People with a body mass index (BMI) of 28 kg/m\^2 or higher or 24 kg/m\^2 or higher with at least 1 weight related problem can join the study. The main purpose of this s…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New eczema pill shows promise in late-stage trial
Symptom relief CompletedThis is a randomized, double-blind study comparing LNK01001 to placebo in participants with moderately to severely atopic dermatitis who were candidates for systemic therapy (ie, patients with a history of inadequate response to topical treatments, those who were using a systemic…
Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New hope for rare cancers: drug combo targets BRAF mutation
Disease control Recruiting nowThis study is a phase IV, pragmatic single-arm prospective, open label study in pediatric (1 years or older) and adult study participants with rare BRAF V600E mutation-positive unresectable or metastatic solid tumors for whom a decision has already been made to be treated with da…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for lymphoma patients: drug combo aims to keep cancer at bay longer
Disease control Recruiting nowFollicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective ep…
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug combo could spare chemo for some breast cancer patients
Disease control Recruiting nowADAPT-HER2-IV will address question of optimal neoadjuvant therapy in patients with less advanced -HER2+ EBC. ADAPT-HER2-IV is planned as a superiority trial to demonstrate higher pCR rates in both clinically relevant subgroups of low-intermediate risk HER2+ EBC. Moreover, it ai…
Phase: PHASE2 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Nerve switch surgery aims to restore arm movement in paralysis
Disease control Recruiting nowThe goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury. Participants will: * undergo standard of care pre- and post-op testing and study exam…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Growing heart valve could spare kids repeat surgeries
Disease control OngoingProspective, single-arm, multi-center study to evaluate safety and effectiveness of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years requiring surgical pulmonary valve replacement. The Autus Valve may be expanded pre-implant to match the subject's …
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for tough lymphoma: phase 3 trial pits SHR2554 against standard drug
Disease control Recruiting nowThis study was designed to compare the efficacy and safety of SHR2554 with Chidamide in patients with relapsed/refractory PTCL.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo therapy aims to save rectums from surgery in rectal cancer trial
Disease control Recruiting nowphase II clinical trial to evaluate node-sparing short-course radiation combined with total neoadjuvant CAPOX and Sintilimab for MSS locally advanced rectal cancers.
Phase: PHASE2 • Sponsor: Jinhua Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood protein test aims to catch liver cancer sooner
Diagnosis Recruiting nowBy collecting blood samples from liver cancer patients and healthy individuals, and comparing the blood protein profiles of the two, the biomarkers for early diagnosis and tissue traceability were identified to accurately establish an early diagnosis model for liver cancer and ve…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
New pill targets Hard-to-Treat KRAS cancers in early human trial
Disease control Recruiting nowThis is a multicenter, open-label phase 1/2 study consisting of two parts: dose escalation phase and dose expansion phase. The objective of the dose escalation phase is to evaluate the safety, tolerability and pharmacokinetics of HYP-2090PTSA in patients with advanced solid tumor…
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Glowing dye helps surgeons remove stomach cancer while saving healthy tissue
Disease control Recruiting nowThe main treatment for early gastric cancer (EGC) include endoscopic submucosal dissection (ESD) and radical gastrectomy. However, appropriate treatment for patients who exceed the absolute indications and noncurative resection of ESD remains unestablished. Sentinel node navigati…
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take on lupus in first human test
Disease control Recruiting nowThis is a Phase 1 study of obecabtagene autoleucel (obe-cel), autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19, to establish the tolerability, safety, preliminary efficacy, and pharmacokinetics of obe-cel in patients with severe, refractory SLE.
Phase: PHASE1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Radiation boost may extend life in advanced kidney cancer
Disease control Recruiting nowRenal cancer ranks seventh in incidence among men and sixth among women in the Beijing area, with Peking University First Hospital treating over 1,000 kidney cancer patients annually. Once recurrence or metastasis occurs, the prognosis is poor, with median progression times of 1-…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI blood test could spot heart attacks faster
Diagnosis Recruiting nowThe goal of this observational study is to evaluate whether artificial intelligence (AI) algorithms can predict or exclude acute coronary syndrome (ACS) in adults using data generated by routine hematology testing. The main questions the study aims to answer are: * Can AI algori…
Sponsor: RobotDreams GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Tailor-Made cancer therapies tested in unique N-of-1 trial
Disease control Recruiting nowThe purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Scientists uncover hidden electrical switch that fuels colorectal Cancer's spread
Knowledge-focused CompletedSpatial heterogeneity represents a pivotal driver of therapeutic resistance and metastatic progression in colorectal cancer (CRC). However, the mechanical regulatory mechanisms governing intratumoral regional specialization remain incompletely understood. This study integrates sp…
Sponsor: Ma Tianyi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a common ED drug help COPD patients breathe easier?
Disease control Recruiting nowERASE PH-COPD is a randomized double-blind study, with 2 parallel groups. Patients with severe pulmonary hypertension due to chronic obstructive pulmonary disease, will be randomly assigned to receive Tadalafil orally or placebo.
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC